Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Carcinoma, Hepatocellular 3Colorectal Neoplasms 2Pancreatic Neoplasms 1Neoplasms 1Liver Neoplasms 1Hematologic Neoplasms 1Hematologic Diseases 1Febrile Neutropenia 1Clostridium Infections 1

Interventions

pegylated granulocyte colony-stimulating factor 3Interleukin 1 Receptor Antagonist Protein 2Filgrastim 2pegfilgrastim 1Vancomycin 1Piperacillin, Tazobactam Drug Combination 1Meropenem 1Linezolid 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Febrile Neutropenia × Vancomycin × Clear all
NCT02732327 2017-07-21

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Forest Laboratories

Phase 2 Terminated
2 enrolled 2 charts
Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡